Conference Coverage

This channel highlights DAIC's coverage of numerous key cardiology and medical imaging conferences each year. These include ACC, AHA, ASE, ASNC, EuroPCR, ECR, HIMSS, HRS, RSNA, SCAI, SCCT, TCT, and VIVA.

An advanced CT test can identify individuals with stable angina at a reduced risk of three-year adverse outcomes despite their having a high coronary artery calcium score

News | Computed Tomography (CT)

CT Test Simulates Blood Flow to Assess Risk in Patients with Angina

September 19, 2023 — An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

September 19, 2023

They are the only hospitals in New Jersey to earn this elite distinction and provide world-class patient care through a sustainable quality improvement program

News | Cardiovascular Business

Five Hackensack Meridian Hospitals Nationally Recognized for Excellence with ACC HeartCARE Center Designations

September 15, 2023 — The American College of Cardiology (ACC) has recognized five Hackensack Meridian Health hospitals ...

September 15, 2023

University Hospitals Harrington Heart & Vascular Institute first to adopt technology in U.S.

News | Cath Lab

New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

September 13, 2023

The analysis of the health records found that, on average, participants’ systolic blood pressure increased by up to 1.7 mm Hg in the winter months compared to the summer months

News | Hypertension

Study from AHA Hypertension Scientific Sessions Reports on Cold Weather’s Impact on Treating High Blood Pressure

September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...

September 13, 2023

Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).

News | Cardiovascular Clinical Studies

Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...

September 12, 2023

Quality Improvement and Education Program sponsored by Amgen, Esperion to improve adherence to guideline recommendations for managing LDL

News | ACC

American College of Cardiology Program to Increase Cholesterol Screenings

September 12, 2023 — The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...

September 12, 2023

Premier cardiovascular digital health experience continues cultivating a community to examine and solve for future complex healthcare needs

News | Cardiovascular Business

HRX 2023 Conference Propelling the Future of Digital Health

September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...

September 11, 2023

Recipient of the Harry Goldblatt Award for New Investigators from the American Heart Association’s 2023 Hypertension Council

News | Hypertension

Faulkner to be Honored by American Heart Association

September 7, 2023 —Jessica Faulkner, PhD, a physiologist whose research is focused on sex differences in cardiovascular ...

September 07, 2023

Annual Scientific Symposium will take place October 23-26 in San Francisco

Feature | TCT

CRF Announces TCT 2023 Late-breaking Clinical Trials

September 6, 2023 — The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical ...

September 06, 2023

Results from Two Phase 3 studies evaluating CAMZYOS (mavacamten) for symptomatic obstructive hypertrophic cardiomyopathy (HCM) were recently released by Bristol Myers Squibb.

News | Cardiovascular Clinical Studies

Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Released

September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in ...

September 05, 2023

News | Cardiac Diagnostics

Wireless Handheld Ultrasound Device Launched by GE HealthCare for Rapid Assessment of Cardiac and Vascular Patients

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

September 05, 2023

CASTLE-HTx trial presented in a Hot Line session at ESC Congress 2023

News | Atrial Fibrillation

Atrial Fibrillation Ablation Improves Outcomes in Patients with End-stage Heart Failure

August 31, 2023 — Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or ...

August 31, 2023

ECLS-SHOCK trial presented in a Hot Line session at ESC Congress 2023

News | Cardiovascular Clinical Studies

ECLS-SHOCK Trial Reports Mortality Data for Extracorporeal Life Support

August 31, 2023 — Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial ...

August 31, 2023

This is the first international guideline document to include all cardiomyopathy subtypes

News | Congenital Heart

First International Guidelines on Heart Muscle Diseases Published

August 31, 2023 — The European Society of Cardiology (ESC) Guidelines on cardiomyopathies are published online in Europe ...

August 31, 2023

Non-inferiority and safety of one-month DAPT with BIOTRONIK’s drug-eluting stent presented as late-breaker at ESC 2023

News | Cardiovascular Clinical Studies

12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT

August 30, 2023 — BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ...

August 30, 2023